People: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

26.25USD
23 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$26.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,193,707
52-wk High
$32.00
52-wk Low
$15.64

Search Stocks

Moore, Terrence 

Brief Biography

Mr. Terrence O. Moore serves as Executive Vice President, Chief Commercial Officer of ACADIA Pharmaceuticals Inc., with effect from August 19, 2013. Mr. Moore has more than 25 years of experience as a senior member of sales and marketing teams at several pharmaceutical companies. He has made key contributions to the building of multi-billion dollar brands in the CNS field, including Prozac®, Zyprexa®, Risperdal®, and Effexor XR®. Prior to joining, Mr. Moore was a Principal of Cooke-Moore Consulting and, before founding that firm, served as Vice President at Transcept Pharmaceuticals, where he was responsible for commercial strategy, business development, and commercial alliance activities. Previously, Mr. Moore served as Vice President, U.S. Head of Neuroscience Marketing at Organon BioSciences and was responsible for the creating and building its Neuroscience Business Unit. He also served as Vice President, U.S. Marketing, Effexor XR®, as well as Vice President, Global Strategy Depression Portfolio at Wyeth Pharmaceuticals. Earlier, Mr. Moore held senior management positions at Johnson & Johnson, where he helped to launch Risperdal® for additional indications in the U.S., and at Eli Lilly, where he held various sales and marketing roles over 11 years, including Zyprexa® Brand Manager. Mr. Moore holds a B.S. degree in Pharmacy from the University of Florida, a B.A. degree in Chemistry from the University of South Florida and has completed executive development programs at the Kellogg School of Management and Wharton School of Business.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
178,128 -- 2,274,330 2,452,450

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leslie Iversen

--

Uli Hacksell

4,818,870

Stephen Davis

--

Roger Mills

2,876,290

Terrence Moore

2,452,450

Glenn Baity

2,135,770
As Of 30 Dec 2013
Search Stocks